Specialized Services

---

Developed over 100 drug dossiers in 20+ years to inform pricing, funding, and negotiations of medicines at all stages of the lifecycle

Conceptualized and conducted over 80 pharmacoeconomic analyses and economic models to drive decisions on payment and access to medications for patients

Synthesized evidence and generated reports for government and payer drug formulary access-decision makers for 100's of unique reviews, across numerous disease areas including cardiovascular, diabetes, oncology, immunology, asthma, mental health disorders, HIV, hepatitis, and beyond